ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2426

Prevalence and Characteristics of Sleep Problems in Rheumatoid Arthritis: A Systematic Review of the Literature

Cassandra Coleman1 and Yvonne C. Lee2, 1Rheumatology, Brigham and Women's Hospital, Boston, MA, 2Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Rheumatoid arthritis (RA), sleep and sleep disorders

  • Tweet
  • Email
  • Print
Session Information

Title: Psychology/Social Sciences

Session Type: Abstract Submissions (ARHP)

Background/Purpose: Rheumatoid arthritis (RA) patients commonly complain of sleep problems.  Difficulties with sleep may be associated with increased fatigue, greater pain and worse quality of life.  We aimed to establish the prevalence of sleep problems among RA patients and to characterize these sleep problems based on survey and polysomnographic measurements.

Methods: We conducted a systematic literature review to identify studies reporting the prevalence and characteristics of sleep problems in RA.  Pubmed searches were conducted using MESH keywords for “Arthritis, Rheumatoid,” “Sleep,” Sleep Disorders”, and “Fatigue”, for studies published worldwide in English between August 1989 and April 2012. Further articles were obtained from the reference lists of these articles.  Articles were selected based on title, abstract and manuscript review.  Inclusion criteria included studies focusing on sleep problems in adult-onset RA patients.  Review articles, case reports, and qualitative studies were excluded. One author (CC) screened titles and abstracts. Both authors independently extracted data from the articles. Data regarding the prevalence of sleep problems and specific types of sleep problems were extracted, and ranges of values and median of means are reported.

Results: The literature search identified 1410 articles of which 23 were included in the review.  Of these articles, 8 had specific measures of the prevalence of sleep problems, and 18 used survey and/or polysomnograph methods to characterize these problems based on sleep duration, sleep efficiency and sleep disturbance.  Only 5 articles had data comparing RA patients to controls (Table). Methods and scales for evaluating prevalence and characteristics of sleep disturbances varied greatly among these articles. The prevalence of sleep problems ranged from 60-97% by self-report questionnaires.  The Pittsburgh Sleep Quality Index score, reflecting sleep quality, sleep latency, sleep efficiency, sleep disturbance, and sleep duration, was markedly higher, signifying poorer sleep, in RA patients compared to control patients. Polysomnograph studies also indicated lower sleep efficiency, increased number of awakenings, and longer sleep latency among RA patients compared to control subjects.  However, mean hours of sleep, measured by polysomnograph, were similar among RA patients compared to controls.

Conclusion: Sleep disturbances, notably increased awakenings, were reported by the majority of RA patients, while sleep duration was similar among RA patients compared to controls.  These results suggest that widespread sleep problems among RA patients may be a result of disturbed sleep rather than an overall lack of sleep. Future studies are needed using uniform sleep measures in large cohorts of well-characterized RA patients with appropriately selected controls.  

  

Table. Median of means and ranges of reported values for survey and polysomnograph measures among RA patients and controls.

Clinical Characteristics

Median of Means

(Range of Values)

Number of Studies

Rheumatoid Arthritis

Controls

  Survey Measures

 

 

 

       Pittsburgh Sleep Quality Index 1

8.5 (7.6 – 9.5)

2.6 (2.4 – 2.8)

2

  Polysomnograph Measures

 

 

 

        Mean Hours of Sleep (hrs)

6.3 (5 – 7.2)

6.9 (6 – 7.6)

4

        Sleep Efficiency (%)

80.9 (61 – 93.6)

90.8 (85 – 94)

4

        Number of Awakenings

67.6 (3.1 – 194)

7.4 (2.6 – 112)

4

        Sleep Latency (min)

25.1 (21.8 – 30.5)

13.7 (12.1 – 25.2)

4

1Range = 0-21, PSQI score < 5 = “good sleeper”, PSQI > 5 = “poor sleeper”

 


Disclosure:

C. Coleman,
None;

Y. C. Lee,

Forest Laboratories,

2,

Merck Pharmaceuticals,

1,

Novartis Pharmaceutical Corporation,

1,

Elan Corporation,

1.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-and-characteristics-of-sleep-problems-in-rheumatoid-arthritis-a-systematic-review-of-the-literature/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology